A practical guide exploring how the quality of regulatory documentation directly affects submission review timelines and approval outcomes. Covers common errors in CSRs and CTD narratives, the cost of poor documentation, and what review-ready documents actually look like. Ideal for regulatory affairs managers and CMC teams at mid-size pharma companies preparing for NDA or MAA submissions.
